---
title: Combined inhibition of ribonucleotide reductase and WEE1 induces synergistic
  anticancer activity in Ewing's sarcoma cells
date: '2025-02-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39962391/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250218170842&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our findings show that combined inhibition of RNR and WEE1
  was effective against Ewing''s sarcoma in vitro. They thus provide a rationale for
  the evaluation of the potential of combined targeting of RNR and WEE1 in Ewing''s
  sarcoma in ...'
disable_comments: true
---
CONCLUSION: Our findings show that combined inhibition of RNR and WEE1 was effective against Ewing's sarcoma in vitro. They thus provide a rationale for the evaluation of the potential of combined targeting of RNR and WEE1 in Ewing's sarcoma in ...